JP2000513340A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000513340A5 JP2000513340A5 JP1998501656A JP50165698A JP2000513340A5 JP 2000513340 A5 JP2000513340 A5 JP 2000513340A5 JP 1998501656 A JP1998501656 A JP 1998501656A JP 50165698 A JP50165698 A JP 50165698A JP 2000513340 A5 JP2000513340 A5 JP 2000513340A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9612297.3 | 1996-06-11 | ||
| GBGB9612297.3A GB9612297D0 (en) | 1996-06-11 | 1996-06-11 | Medicinal aerosol formulations |
| PCT/US1997/009471 WO1997047286A1 (en) | 1996-06-11 | 1997-06-02 | Medicinal aerosol formulations of formoterol |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2000513340A JP2000513340A (ja) | 2000-10-10 |
| JP2000513340A5 true JP2000513340A5 (enExample) | 2005-02-10 |
| JP5000793B2 JP5000793B2 (ja) | 2012-08-15 |
Family
ID=10795182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50165698A Expired - Lifetime JP5000793B2 (ja) | 1996-06-11 | 1997-06-02 | 医用ホルモテロールエアゾール製剤 |
Country Status (16)
| Country | Link |
|---|---|
| EP (2) | EP0934057B1 (enExample) |
| JP (1) | JP5000793B2 (enExample) |
| AR (1) | AR009231A1 (enExample) |
| AT (1) | ATE275940T1 (enExample) |
| AU (1) | AU726382B2 (enExample) |
| CA (1) | CA2257841C (enExample) |
| DE (1) | DE69730723T2 (enExample) |
| DK (1) | DK0934057T3 (enExample) |
| ES (1) | ES2229366T3 (enExample) |
| GB (1) | GB9612297D0 (enExample) |
| ID (1) | ID19520A (enExample) |
| NO (1) | NO320403B1 (enExample) |
| NZ (1) | NZ333202A (enExample) |
| PT (1) | PT934057E (enExample) |
| WO (1) | WO1997047286A1 (enExample) |
| ZA (1) | ZA974546B (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6054488A (en) * | 1996-06-11 | 2000-04-25 | 3M Innovative Properties Company | Medicinal aerosol formulations of formoterol |
| GB9616237D0 (en) | 1996-08-01 | 1996-09-11 | Norton Healthcare Ltd | Aerosol formulations |
| US20010031244A1 (en) | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
| US6423298B2 (en) * | 1998-06-18 | 2002-07-23 | Boehringer Ingelheim Pharmaceuticals, Inc. | Pharmaceutical formulations for aerosols with two or more active substances |
| US6451285B2 (en) * | 1998-06-19 | 2002-09-17 | Baker Norton Pharmaceuticals, Inc. | Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant |
| DE19847969A1 (de) * | 1998-10-17 | 2000-04-20 | Boehringer Ingelheim Pharma | Lagerfähig flüssige Formulierung mit Formoterol |
| EA003960B1 (ru) * | 1998-10-17 | 2003-10-30 | Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг | Устойчивый при хранении концентрат биологически активного вещества формотерола |
| DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
| IT1303788B1 (it) | 1998-11-25 | 2001-02-23 | Chiesi Farma Spa | Formulazioni di aerosol medicinali. |
| US6004537A (en) * | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
| US6290930B1 (en) | 1998-12-18 | 2001-09-18 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide |
| IT1313553B1 (it) | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
| IT1317846B1 (it) | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
| CN1213732C (zh) * | 2000-05-22 | 2005-08-10 | 奇斯药制品公司 | 用于加压计量吸入器的稳定药用溶液制剂 |
| SE0004750D0 (sv) | 2000-12-19 | 2000-12-19 | Astrazeneca Ab | Novel formulation |
| US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| ATE267591T1 (de) | 2001-07-02 | 2004-06-15 | Chiesi Farma Spa | Optimierte tobramycin-formulierung zur aerosolbildung |
| AR036358A1 (es) * | 2001-08-28 | 2004-09-01 | Schering Corp | Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma |
| GB0207906D0 (en) * | 2002-04-05 | 2002-05-15 | 3M Innovative Properties Co | Formoterol and mometasone aerosol formulations |
| GB0207899D0 (en) * | 2002-04-05 | 2002-05-15 | 3M Innovative Properties Co | Formoterol and cielesonide aerosol formulations |
| CA2495875C (en) * | 2002-08-27 | 2010-06-22 | Schering Corporation | Process for producing metered dose inhaler formulations |
| AU2004246819A1 (en) * | 2003-06-13 | 2004-12-23 | Nycomed Gmbh | Formoterol and ciclesonide combination |
| TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
| EP1925293A3 (en) * | 2003-10-20 | 2010-01-13 | Schering Corporation | Pharmaceutical aerosol compositions |
| JP2007509147A (ja) * | 2003-10-20 | 2007-04-12 | シェーリング コーポレイション | 薬学的エアロゾル組成物 |
| EP1595531A1 (en) | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
| EP2077830B1 (en) * | 2006-10-17 | 2012-11-07 | Lithera, Inc. | Methods, compositions, and formulations for the treatment of thyroid eye disease |
| ES2774367T3 (es) | 2009-05-29 | 2020-07-20 | Pearl Therapeutics Inc | Composiciones para el suministro respiratorio de agentes activos y métodos y sistemas asociados |
| US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
| HRP20140818T1 (hr) * | 2009-10-02 | 2014-10-10 | Chiesi Farmaceutici S.P.A. | Farmaceutske aerosolne formulacije formoterola i beklometazon-dipropionata |
| US20140275517A1 (en) | 2013-03-15 | 2014-09-18 | Pearl Therapeutics, Inc. | Methods and systems for conditioning of particulate crystalline materials |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05508616A (ja) * | 1989-02-23 | 1993-12-02 | ローヌー プーラン ローラー インターナショナル（ホウルディングス）インコーポレイテッド | 治療用エアロゾル剤 |
| IL97065A (en) * | 1990-02-02 | 1994-01-25 | Fisons Plc | Repellent preparations for aerosol |
| GB9024365D0 (en) * | 1990-11-09 | 1991-01-02 | Glaxo Group Ltd | Medicaments |
| EP0504112A3 (en) * | 1991-03-14 | 1993-04-21 | Ciba-Geigy Ag | Pharmaceutical aerosol formulations |
| SK140493A3 (en) * | 1991-06-10 | 1994-10-05 | Schering Corp | Non-chlorofluorocarbon aerosol formulations |
| EP1277467B1 (en) * | 1991-06-10 | 2006-09-20 | Schering Corporation | Non-chlorofluorocarbon aerosol formulations |
| DE69205177T2 (de) * | 1991-12-12 | 1996-03-21 | Glaxo Group Ltd., Greenford, Middlesex | Pharmazeutische Aerosolformulierung. |
| IL104068A (en) * | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant |
| EP0617610B1 (en) * | 1991-12-18 | 1997-03-19 | Minnesota Mining And Manufacturing Company | Suspension aerosol formulations |
| GB9207400D0 (en) * | 1992-04-02 | 1992-05-13 | Smithkline Beecham Plc | Novel use |
| US5354934A (en) * | 1993-02-04 | 1994-10-11 | Amgen Inc. | Pulmonary administration of erythropoietin |
| GB9425160D0 (en) * | 1994-12-10 | 1995-02-08 | Glaxo Group Ltd | Medicaments |
| GB9426252D0 (en) * | 1994-12-24 | 1995-02-22 | Glaxo Group Ltd | Pharmaceutical composition |
-
1996
- 1996-06-11 GB GBGB9612297.3A patent/GB9612297D0/en active Pending
-
1997
- 1997-05-23 ZA ZA974546A patent/ZA974546B/xx unknown
- 1997-06-02 AT AT97929756T patent/ATE275940T1/de not_active IP Right Cessation
- 1997-06-02 DK DK97929756T patent/DK0934057T3/da active
- 1997-06-02 AU AU33739/97A patent/AU726382B2/en not_active Expired
- 1997-06-02 ES ES97929756T patent/ES2229366T3/es not_active Expired - Lifetime
- 1997-06-02 DE DE69730723T patent/DE69730723T2/de not_active Expired - Lifetime
- 1997-06-02 EP EP97929756A patent/EP0934057B1/en not_active Expired - Lifetime
- 1997-06-02 PT PT97929756T patent/PT934057E/pt unknown
- 1997-06-02 NZ NZ333202A patent/NZ333202A/en not_active IP Right Cessation
- 1997-06-02 WO PCT/US1997/009471 patent/WO1997047286A1/en not_active Ceased
- 1997-06-02 EP EP03014565A patent/EP1400239A1/en not_active Withdrawn
- 1997-06-02 CA CA002257841A patent/CA2257841C/en not_active Expired - Lifetime
- 1997-06-02 JP JP50165698A patent/JP5000793B2/ja not_active Expired - Lifetime
- 1997-06-04 AR ARP970102437A patent/AR009231A1/es unknown
- 1997-06-09 ID IDP971970A patent/ID19520A/id unknown
-
1998
- 1998-12-07 NO NO19985720A patent/NO320403B1/no unknown